AUPH FY 2022 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$134M+193.9% YoY

Gross Profit

$128M95.8% margin

Operating Income

-$111M-83.2% margin

Net Income

-$108M-80.7% margin

EPS (Diluted)

$-0.76

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$80M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$471M

Total Liabilities

$65M

Stockholders' Equity

$405M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$134M	$46M	+193.9%
Gross Profit	$128M	$45M	+188.4%
Operating Income	-$111M	-$181M	+38.3%
Net Income	-$108M	-$181M	+40.2%